Mechanisms of Disease: a 'DAMP' view of inflammatory arthritis

被引:278
作者
Foell, Dirk [1 ]
Wittkowski, Helmut [1 ]
Roth, Johannes [1 ]
机构
[1] Univ Munster, Dept Pediat, D-48149 Munster, Germany
来源
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2007年 / 3卷 / 07期
关键词
arthritis; DAMPs; innate immunity; necrosis; pattern recognition;
D O I
10.1038/ncprheum0531
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Innate immunity achieves our primary host defense by recognizing invading microorganisms through pathogen-associated molecular patterns (PAMPs) and by reacting to tissue damage signals called damage-associated molecular patterns (DAMPs). DAMP molecules, including high mobility group box 1 protein (HMGB-1), heat-shock proteins (HSPs), uric acid, altered matrix proteins, and S100 proteins, represent important danger signals that mediate inflammatory responses through the receptor for advanced glycation end-products ( RAGE, also known as AGER) and Toll-like receptors, after release from activated or necrotic cells. The terms 'alarmins' and 'endokines' have also been proposed for DAMP molecules. A prototypic DAMP molecule, the nuclear protein HMGB-1, is either passively released by necrotic cells or actively secreted with delay by activated cells. S100A8, S100A9, and S100A12 are calcium-binding proteins expressed in the cytoplasm of phagocytes. They are rapidly secreted by activated monocytes or neutrophils, which are abundant in inflamed synovial tissue. HSPs are involved in the crosstalk between innate and adaptive immune systems, and primarily mediate immune regulatory functions. Multiple positive feedback loops between DAMPs and PAMPs and their overlapping receptors temporally and spatially drive these processes and may represent the molecular basis for the observation that infections, as well as nonspecific stress factors, can trigger flares in rheumatic diseases.
引用
收藏
页码:382 / 390
页数:9
相关论文
共 60 条
  • [1] BIANCHI ME, J LEUKOC BIOL
  • [2] Understanding RAGE, the receptor for advanced glycation end products
    Bierhaus, A
    Humpert, PM
    Morcos, M
    Wendt, T
    Chavakis, T
    Arnold, B
    Stern, DM
    Nawroth, PP
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11): : 876 - 886
  • [3] Bierhaus A, 2006, CURR OPIN INVEST DR, V7, P985
  • [4] Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO
  • [5] 2-2
  • [6] Butler DM, 1997, J IMMUNOL, V159, P2867
  • [7] Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products
    Cecil, DL
    Johnson, K
    Rediske, J
    Lotz, M
    Schmidt, AM
    Terkeltaub, R
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (12) : 8296 - 8302
  • [8] CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis
    de Kleer, IM
    Wedderburn, LR
    Taams, LS
    Patel, A
    Varsani, H
    Klein, M
    de Jager, W
    Pugayung, G
    Giannoni, F
    Rijkers, G
    Albani, S
    Kuis, W
    Prakken, B
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (10) : 6435 - 6443
  • [9] Di Virgilio Francesco, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P85
  • [10] Role for innate immunity in rheumatoid arthritis
    Falgarone, G
    Jaen, O
    Boisser, MC
    [J]. JOINT BONE SPINE, 2005, 72 (01) : 17 - 25